Inventor · disambiguated record
Kathleen Mcginness
Also filed as: MCGINNESS KATHLEEN
5 granted patents·9 pending applications·30 citations·filing 2010–2024
75Inventor score
Top patents by PatentIndex Score
14 records- 0190US10144770B2Chimeric receptors and uses thereof in immune therapyNAT UNIV SINGAPORE·Filed 2014·Granted Dec 4, 2018·16 cites·31 claims
- 0283US8598327B2Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeuticsSCHAUB ROBERT·Filed 2011·Granted Dec 3, 2013·10 cites·19 claims
- 0376US8252913B2Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeuticsSCHAUB ROBERT G·Filed 2010·Granted Aug 28, 2012·4 cites·36 claims
- 0466US2024376442A1Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating krebs cycle and therapeutic uses thereofSOTIO BIOTECH INC·Filed 2024·Application pending·0 cites
- 0559US12077785B2Chimeric antigen receptor polypeptides in combination with trans metabolism molecules modulating Krebs cycle and therapeutic uses thereofSOTIO BIOTECH INC·Filed 2019·Granted Sep 3, 2024·0 cites·23 claims
- 0653US2025114465A1Rna degraders and uses thereofARRAKIS THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0750US8461318B2Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder thereapeuticsSCHAUB ROBERT·Filed 2011·Granted Jun 11, 2013·0 cites·1 claims
- 0850US2024390495A1Chimeric receptor polypeptides in combination with trans metabolism molecules that re-direct glucose metabolites out of the glycolysis pathway and therapeutic uses thereofSOTIO BIOTECH INC·Filed 2022·Application pending·0 cites
- 0948US2021340219A1Chimeric receptor polypeptides in combination with trans metabolism molecules modulating intracellular lactate concentrations and therapeutic uses thereofSOTIO LLC·Filed 2019·Application pending·0 cites
- 1047US2022054545A1ANTI-GPC3 CHIMERIC ANTIGEN RECEPTORS (CARs) IN COMBINATION WITH TRANS CO-STIMULATORY MOLECULES AND THERAPEUTIC USES THEREOFSOTIO LLC·Filed 2019·Application pending·0 cites
- 1147US2021261646A1Chimeric receptors in combination with trans metabolism molecules enhancing glucose import and therapeutic uses thereofSOTIO LLC·Filed 2019·Application pending·0 cites
- 1241US2019112349A1Modified chimeric receptors and uses thereof in immune therapyUNUM THERAPEUTICS INC·Filed 2017·Application pending·0 cites
- 1338US2020181226A1Antibody-coupled t cell receptor constructs and therapeutic uses thereofUNUM THERAPEUTICS INC·Filed 2018·Application pending·0 cites
- 1432US2018133252A9Chimeric receptors and uses thereof in immune therapyUNUM THERAPEUTICS INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Kathleen Mcginness files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →